Nektar Therapeutics Share Price
NASDAQ: NKTRHealthcare
Live Nektar Therapeutics Share Price Chart
O H L
Nektar Therapeutics Performance Overview
Days Range
▼
$67.75Low
$68.57High
Markets Today
| Previous Close | $68.36 |
|---|---|
| Open | $68.40 |
| Volume | 68,682 |
| Day's Range | $67.75 - $68.57 |
| 52W Range | $33.40 - $109.00 |
| Market Cap | $2.30 B |
Historical Performance
| 1M Returns | -7.17 |
|---|---|
| 3M Returns | +12.10 |
| 6M Returns | -6.59 |
| 1Y Returns | +16.34 |
| 5Y Returns | -72.40 |
| 10Y Returns | -76.00 |
Nektar Therapeutics Fundamentals
| Market Cap | $2.30 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $55.23 M |
| ROE TTM | -2.18 |
| EPS TTM | $-6.69 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.55 |
| EBITDA | $-129.75 M |
| Profit Margin | -297.07 |
| Market Cap | $2.30 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $55.23 M |
| ROE TTM | -2.18 |
| EPS TTM | $-6.69 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.55 |
| EBITDA | $-129.75 M |
| Profit Margin | -297.07 |
Nektar Therapeutics Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $10.46 M | $11.18 M | $11.79 M | $21.81 M | $10.86 M | $10.13 M |
| Gross Profit + | $10.46 M | $11.18 M | $11.79 M | $21.81 M | $10.86 M | $10.13 M |
| Operating Income | -$44.53 M | -$36.23 M | -$31.67 M | -$27.66 M | -$39.05 M | -$42.34 M |
| EBITDA | -$43.94 M | -$35.57 M | -$31.34 M | -$18.90 M | -$38.11 M | -$41.61 M |
| Interest Expense | -$4.97 M | -$5.39 M | -$6.05 M | -$9.77 M | -$7.94 M | -$7.21 M |
| Depreciation | $595.00 K | $661.00 K | $336.00 K | $8.77 M | $947.00 K | $734.00 K |
| Income Before Tax | -$46.37 M | -$41.78 M | -$35.02 M | -$34.70 M | -$43.09 M | -$40.62 M |
| Income Tax Expense | $52.00 K | -$188.00 K | -$33.00 K | $31.00 K | $64.00 K | $2.00 K |
| Net Income + | -$50.88 M | -$41.59 M | -$35.52 M | -$36.08 M | -$44.90 M | -$40.62 M |
| Net Profit Margin | -486.44% | -372.2% | -301.29% | -165.45% | -413.44% | -400.97% |
Nektar Therapeutics Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $19.00 K | $1.00 K | $2.00 K | $2.00 K | $3.00 K | $3.00 K |
| Reserve & Surplus | -$3.65 B | -$3.69 B | -$3.72 B | -$3.76 B | -$3.81 B | -$3.85 B |
| Non-Current Liabilities | $171.57 M | $160.35 M | $149.92 M | $137.04 M | $129.35 M | $121.02 M |
| Current Liabilities | $70.93 M | $71.39 M | $66.34 M | $53.54 M | $57.71 M | $70.98 M |
| Total Liabilities | $242.50 M | $231.75 M | $216.26 M | $190.57 M | $187.06 M | $192.01 M |
| Fixed Assets | $3.16 M | $2.99 M | $2.83 M | $0 | $0 | $0 |
| Current Assets | $229.91 M | $186.57 M | $281.36 M | $266.27 M | $589.04 M | $739.40 M |
| Total Assets | $256.24 M | $207.53 M | $301.35 M | $280.41 M | $763.27 M | $1.10 B |
Nektar Therapeutics Cash Flow
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$36.08 M | -$36.08 M | -$44.90 M | -$44.90 M | -$40.62 M | -$40.62 M |
| Operating Cash Flow | -$64.96 M | -$64.96 M | -$44.30 M | -$44.30 M | -$75.77 M | -$75.77 M |
| Investing Cash Flow | $372.00 K | $372.00 K | -$350.79 M | -$350.79 M | -$399.11 M | -$399.11 M |
| Financing Cash Flow | $38.67 M | $38.67 M | $529.55 M | $529.55 M | $364.57 M | $364.57 M |
| Change in Cash | -$25.92 M | -$25.92 M | $134.46 M | $134.46 M | -$110.31 M | -$110.31 M |
Nektar Therapeutics Return Calculator
The Nektar Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,713
Invested Amount$10,000
Est. Returns$-7,287
About Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Popular Stocks
FAQs
What is the share price of Nektar Therapeutics today?
Nektar Therapeutics (NKTR) share price as of September 18, 2026 is $67.18. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Nektar Therapeutics?
Yes, Indian Investors can invest in the Nektar Therapeutics (NKTR) Share by opening an international trading account with Angel One.
How can I purchase Nektar Therapeutics shares in India?
Purchasing Nektar Therapeutics (NKTR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Nektar Therapeutics (NKTR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Nektar Therapeutics?
Yes, you can purchase fractional shares of Nektar Therapeutics (NKTR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Nektar Therapeutics?
The market capitalization of Nektar Therapeutics on September 18, 2026, is $2.30 B.
In which sector Nektar Therapeutics belongs?
Nektar Therapeutics operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Nektar Therapeutics stocks?
In order to invest in Nektar Therapeutics (NKTR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
